Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use.

N

National Research Institute for Family Planning, China

Status

Not yet enrolling

Conditions

Contraception Behavior
Contraceptive Usage

Treatments

Drug: Compound Norethisterone Enanthate Injection
Other: One-to-one Service
Other: Family Planning Service

Study type

Interventional

Funder types

Other

Identifiers

NCT05362019
2021HX019

Details and patient eligibility

About

This study aims to explore the impact of a mobile based one-to-one service model on improving the continuation and satisfaction of combined injectable contraceptive use, and improve the utilization and acceptability of efficient and long-term contraceptive methods.

Full description

In China, due to the lack of understanding or misunderstanding of hormonal contraception by service providers and the public, the use of combined injectable contraceptive is not common. Therefore, this study aims to explore the impact of a mobile based one-to-one service model on improving the continuation and satisfaction of combined injectable contraceptive use, and improve the utilization and acceptability of efficient and long-term contraceptive methods.

Enrollment

400 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 to 40 years old;
  • Healthy Volunteers;
  • More than 6 months after delivery and without lactation;
  • No fertility intention within 6 months;
  • Normal menstruation;
  • No contraindications to the use of compound contraceptive methods;
  • Had not used hormonal contraception in the previous three months;
  • Understand the content and requirements of the project, be willing to cooperate, and have signed the informed consent form;
  • Have a certian education level, and be able to use the special sanitary napkins to record menstrual volume and menstrual card.

Exclusion criteria

  • Suffering from serious systemic diseases;
  • Previous or current thrombotic disease;
  • Malignant tumor of uterine organ;
  • Unable to communicate normally due to disability or mental or intellectual impairment.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

intervention group
Experimental group
Description:
A mobile phone based "service system" developed by the research group will be used to provide one-to-one service for the intervention group.
Treatment:
Other: One-to-one Service
Drug: Compound Norethisterone Enanthate Injection
control group
Active Comparator group
Description:
Routine family planning services will be provided to the control group.
Treatment:
Other: Family Planning Service
Drug: Compound Norethisterone Enanthate Injection

Trial contacts and locations

8

Loading...

Central trial contact

Denghui Hu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems